Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial
Status:
Completed
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the relative efficacy and safety of treatment of
neovascular AMD with Lucentis on a fixed schedule, Avastin on a fixed schedule, Lucentis on a
variable schedule, and Avastin on a variable schedule.
A five year follow-up visit is being conducted in 2014 to gather information on long term
outcomes.